Joint Agreement Amendment #1 for Operations between Vitro Biopharma, Inc. and European Wellness Group/Biopep
Vitro Biopharma, Inc., European Wellness Group/Biopep, and BioPep (a subsidiary of European Wellness) have signed an amendment to their joint operations agreement as of April 28, 2022. The amendment outlines changes or updates to their existing collaboration, with key representatives from each organization executing the document. The agreement is intended to clarify or modify the terms of their ongoing business relationship.
Exhibit 10.32
Confidential
In witness WHEREOF as of April 28, 2022, the parties have executed this Joint Agreement Amendment #1 for operations for Vitro Biopharma and the European Wellness Group/Biopep.
VITRO BIOPHARMA, INC.
| By: | /s/ Nathan Haas | |
| Name: | Nathan Haas NH. 5.12.22 | |
| Title: | Chief Financial Officer |
EUROPEAN WELLNESS/ BIOPEP
| By: | /s/ Dr. Mike Chan Kok Seng | |
| Name: | Dr. Mike Chan Kok Seng | |
| (Tan Kor Seng ) Passport #A53952903 | ||
| Title: | President and Chief Executive Officer | |
BIOPEP ( A subsidiary of European Wellness)
| By: | /s/Dr.Desiree Cox-Maksimov | |
| Name: | Dr. Desiree Cox – Maksimov MD, PHD | |
| Title: | CEO BioPep |
| 6 | Page |
